52nd week of 2015 patent applcation highlights part 7 |
Patent application number | Title | Published |
20150366724 | PULL-ON DIAPER - A pull-on diaper for younger baby has a transverse direction and a longitudinal direction, front and waist regions, a crotch region, and rear waist regions and leg cuffs extending along respective laterals of the crotch region. Each of front and rear waist panels is sectionalized into a first elastically contractible region and a second elastically contractible region wherein a dimensional ratio in the longitudinal direction between the first elastically contractible region and the second elastically contractible region is in a range of 1:1.6 to 1:2.2 and an elongation ratio of waist elastics attached to the first elastically contractible region is lower than an elongation ratio of the waist elastics attached to the second elastically contractible region and the elongation ratio of the waist elastics attached to the second elastically contractible region is lower than an elongation ratio of second leg elastics. | 2015-12-24 |
20150366725 | DISPOSABLE URINE-ABSORPTION PAD WITH BEDSORE-INHIBITION FUNCTION - Provided is a disposable urine-absorption pad with which production costs are reduced, and with which a function for inhibiting the occurrence or aggravation of bedsores is imparted by facilitating relative movement of a skin-contact sheet in a back-and-forth direction with respect to a pad main body. This urine-absorption pad includes: an outer surface sheet; an absorption body; an inner surface sheet; a left side sheet; a right side sheet; an overlap sheet; and a low friction member. The overlap sheet is provided to a gluteal region. A right side edge of the overlap sheet is joined to a left side part of the right side sheet. A left side edge of the overlap sheet is joined to a right side part of the left side sheet. The low friction member is provided between the overlap sheet and the inner surface sheet. | 2015-12-24 |
20150366726 | ABSORBENT BODY AND ABSORBENT ARTICLE CONTAINING SAID ABSORBENT BODY - An object of the present disclosure is to provide an absorbent body that is both soft and resistant to twisting. The absorbent body of the present disclosure is as follows. An absorbent body for an absorbent article includes thermoplastic resin fibers and cellulose-based water-absorbing fibers, at least some of the thermoplastic resin fibers have a first section | 2015-12-24 |
20150366727 | FOLDABLE ABSORBENT APPARATUS AND METHOD OF USING THE SAME - A foldable absorbent apparatus to ameliorate bleeding of a wound which includes a first and second absorbent pad layer to absorb a fluid, and a malleable material layer enclosed within the first and second absorbent layer configured to be formed in various shapes, wherein the malleable material allows the first and second absorbent pad layers to be formed in various shapes to apply a pressure to a wound while at the same time absorbing fluids from the wound to promote healing of the wound. | 2015-12-24 |
20150366728 | Disposable Absorbent Article with Unitary Topsheet and Unitary Absorbent Article - The present invention relates to disposable absorbent articles such as sanitary napkins, panty liners, baby diapers, adult incontinence articles and sweat pads. According to the present invention the absorbent article in the region designated for liquid deposition on its wearer facing surface has a single layer topsheet onto which liquid to be absorbed is provided during use of the article. The absorbent article includes a backsheet forming the liquid barrier surface and a unitary absorbent core between the topsheet and the backsheet. Importantly the unitary core provides improved liquid handling to the absorbent article and increases the masking, i.e. ability to hide stains due to absorbed liquid, of the article. This is particularly beneficial in the context of articles for absorption of liquids with high color intensity, such as menstrual liquid or urine of older adults. | 2015-12-24 |
20150366729 | Elevator Chair - Described are chairs having a seat with a sitting location above the floor, a base that sits on a floor, a lift connecting the seat and the base, the lift capable of moving the seat up and down from the sitting location to a lower location at the floor, and a control system operating the lift. The control system allows an occupant of the chair to move the seat between its sitting location and the lower location at the floor to enable the occupant to pick up or place an item on the floor while sitting in the chair and thereafter to move the seat upwardly. | 2015-12-24 |
20150366730 | APPARATUS, SYSTEM, AND METHOD FOR A BED WITH AN ACTUATED DECK SECTION - A bed with an actuated deck section. The bed includes a deck section, a non-articulating component, and an actuator. The deck section is configured to articulate. In some embodiments, the actuator is connected to the deck section and the non-articulating component. A portion of the deck section, in one embodiment, is in an elevated position in response to an output rod of the actuator being in a relatively retracted position. | 2015-12-24 |
20150366731 | DECK-ON-DECK ADJUSTABLE BED FRAME - An adjustable foundation includes a base frame and an articulating frame movably supported by the base frame for longitudinal movement with respect to the base frame. A mattress platform is positioned on the articulating frame. A concealing assembly is positioned below the mattress platform and at least partially conceals the base frame. The concealing assembly is attached to the articulating frame for simultaneous longitudinal movement therewith. | 2015-12-24 |
20150366732 | BED WITH MODIFIED FOOT DECK - A bed is provided having a non-pivotal actuation mechanism for a foot deck to assist the bed in being converted to a chair bed and lowered close to the floor even when the foot deck is in a generally vertical position. In one embodiment, the bed has a longitudinal gap between the intermediate deck section and the foot deck section. As the foot deck transitions to the generally vertical position from the generally horizontal position the gap between the intermediate frame section and the foot deck section is decreased. | 2015-12-24 |
20150366733 | Arrangement for Preparing and Positioning Patients to be Treated and/or Cared For Medically - The present invention relates to an arrangement for preparing and positioning patients ( | 2015-12-24 |
20150366734 | Weight Cover - A weight cover ( | 2015-12-24 |
20150366735 | ANATOMICALLY TARGETED COMPRESSION CLOTHING - An item of clothing is adapted to be worn against the skin, and comprises at least one panel adapted to provide targeted compression of at least 20% of the total length of a specific surface vein in the body, or adapted to provide targeted compression of at least 20% of a specific plexus of veins, a specific lymphatic plexus, drainage plexus or a collection of lymphatic vessels. The clothing is useful in a method of reducing recovery time in a human or other mammal, after a period of activity and in a method of enhancing performance, in particular sports performance, in a human or other mammal. It may also improve the conditioning of the skin and aid lymphatic drainage, and can be used in the treatment of certain medical conditions. | 2015-12-24 |
20150366736 | CONTINUOUS PASSIVE MOTION DEVICE - A CPM device includes a support structure arranged to be removably attached to an articulating brace supporting a limb and a joint of a user. One or more rotating members are rotatably connected to the support structure. The rotating members are adapted to contact and roll on an underlying surface that is separate from the CPM device. At least one motor is arranged to apply a torque to the rotating members such that the rotating members roll on the underlying surface. The rolling of the rotating members on the underlying surface causes the support structure to translate over the underlying surface, which, in turn, conveys a bending force to the joint. | 2015-12-24 |
20150366737 | Vein Pump - Disclosed is a motorized dual motion passive action rehabilitation and exercise apparatus for the lower extremities. The use of a fully automatic exercise apparatus allows a person to exercise their lower extremities and achieve adequate range of motion in their ankle, knee, and hip joints without having to engage in active, physical activity or with the assistance of another person. The pre-set speed, motion, and angle of the moving parts of the apparatus provide a steady and optimal movement to maximize therapeutic benefit while preventing injury caused by over excursion of the joints and muscles. The movement achieved by the use of the apparatus allows a person's calves muscles to be contracted and relaxed at an optimal level to encourage blood and lymphatic fluid circulation. | 2015-12-24 |
20150366738 | STEP ASSIST DEVICE, AND COMPUTER-READABLE MEDIUM HAVING STORED THEREON A STEP COUNT PROGRAM - Provided is a step assist device including a first phase angle modifying section that, according to repetition of the step movement, modifies in a staged manner the phase angle input thereto, based on a predetermined phase change pattern, such that a phase pattern of the phase angle approaches a straight line relative to the passage of time, and outputs the modified phase angle as a first modified phase angle. The control section acquires a target value based on a continuous change pattern of the auxiliary force set in advance for at least one of the first modified phase angle and a prescribed phase angle, and controls the providing section according to the target value. | 2015-12-24 |
20150366739 | STEP COUNTER, STEP ASSIST DEVICE, AND COMPUTER-READABLE MEDIUM HAVING STORED THEREON A STEP COUNT PROGRAM - Provided is a step counter including a right angle sensor that outputs a right hip joint angle signal indicating a right hip joint angle of a user; a left angle sensor that outputs a left hip joint angle signal indicating a left hip joint angle of the user; a generating section that generates an angle difference signal indicating change over time of an angle difference between the right hip joint angle and the left hip joint angle, based on the right hip joint angle signal and the left hip joint angle signal; and a calculating section that calculates a step number of the user based on a difference signal generated from a difference between filtered signals resulting from the angle difference signal being applied to at least two different filters. | 2015-12-24 |
20150366740 | STEP COUNTER, STEP ASSIST DEVICE, AND COMPUTER-READABLE MEDIUM HAVING STORED THEREON A STEP COUNT PROGRAM - When performing actuator control using weight on the bottom of the foot as a trigger, the foot of the user must appropriately touch the ground in order for the weight to be sensed. Therefore, the activation condition for starting the actuator control is limited and, for example, a rehabilitation patient who has one injured leg has difficulty training their step movement using this step assist device. Provided is a step assist device including a providing section that provides an assist force to a step movement of a user; a detecting section that detects a hip joint angle, which is an angle of aperture of a hip joint of the user; and a control section that begins controlling the providing section when the hip joint angle exceeds a predetermined threshold value, according to an assistance plan set in advance for the step movement of a single step of the user. | 2015-12-24 |
20150366741 | SUSPENDED BABY WALKER - A suspended baby walker for attaching to a ceiling and allowing vertical and restricted horizontal movement along a suspended track comprises a seat assembly defined as a conventional baby jumper seat, a suspension assembly having a pole portion a suspension connector, and a jumper rope, a mounting assembly defined by a strap connector, a mounting strap and a mounting bracket, and a mounting track which is attached to the ceiling. The seat assembly is rollably attached to the mounting track through the connection of the seat assembly to the suspension assembly, the suspension assembly to the mounting assembly, and the mounting assembly to the mounting track. In operation, a child disposed in the seat assembly can move the seat assembly horizontally back and forth along the length of the mounting track and can jump vertically without placing excess stress on the components due to the elastic nature of the jumper rope. | 2015-12-24 |
20150366742 | AMBULATION SHORTS - Ambulation shorts configured to fit around upper legs and waist of a patient. The ambulation shorts comprise a garment configured to accommodate the upper legs and the waist of the patient, the garment including a gusset panel secured into the groin area thereof. At least one adjustment mechanism is attached to the garment, the adjustment mechanism adapted to allow the garment to be secure with respect to the patient. At least one lifting strap is attached to an upper portion of the garment and configured to be connected to a patient lift. | 2015-12-24 |
20150366743 | Walking Assist Cart - A walking assist cart includes a cart body on which a load can be placed, a drive portion that drives a drive wheel, an inclination sensor that detects the inclination angle of the cart body, and a controller that acquires the weight of the load placed on the cart body based on the drive force of the drive portion and the inclination angle of the cart body and outputs assist drive force based on the weight of the load that is acquired. | 2015-12-24 |
20150366744 | Scalp Scratching Assembly - A scalp scratching assembly for penetrating a hair accoutrement without disturbing the hair accoutrement includes a shaft that has an adjustable length. At least one pad is coupled to an end of the shaft. The at least one pad is textured. The at least one pad may abrade a user's scalp. The at least one pad is insertable through the hair accoutrement. The hair accoutrement remains stationary while the shaft is moved. The at least one pad scratches the user's scalp. | 2015-12-24 |
20150366745 | LONGEUER METHOD TO ACHIEVE BODY ALIGNMENT - The present invention provides methods of improving an individual's body (including spinal alignment), which can lead to an improved overall fitness level, including improved flexibility, length of muscle, range of motion, and/or suppleness. | 2015-12-24 |
20150366746 | Post Workout Massage Device - A massage system includes a frame, a first massage mechanism connected to a first region of the frame to massage a first portion of a user, a second massage mechanism connected to a second region of the frame to massage a second portion of a user, and memory and a processor. The memory is programmed with instructions executable by the processor to determine a massage plan for massaging the at least one of first portion and the second portion. | 2015-12-24 |
20150366750 | PROGRAMMABLE CARDIOPULMONARY RESUSCITATION (CPR) DETECTION DEVICE - Time after time studies find that often, even when administered by trained professionals, cardiopulmonary resuscitation (CPR) compression rates and depth are inadequate. Too week, shallow or too forceful compressions may contribute to suboptimal patient outcome. Several parameters are crucial for optimal and properly-administered CPR. Crucial parameters include proper hand positioning on the patient's chest, depth of compression of 4-5 cm, and compression rate of 100 compressions per minute. The crucial parameters are often affected by patient parameters, and relative to the patient, rescuer parameters, such as patient thoracic volume; weight; age; gender; and rescuer's, relative to the patient's, parameters, such as weight, height; physical form, etc. Proposed is an automated CPR feedback device with user programmable settings for assisting with real-time feedback and subsequently correcting rescuers patient customized CPR technique. | 2015-12-24 |
20150366751 | APPLIANCE FOR CARDIOPULMONARY MASSAGE AND/OR RESUSCITATION - The appliance according to the invention serves for cardiopulmonary massage and/or resuscitation of a patient and is provided with a massage device ( | 2015-12-24 |
20150366752 | Waterfall Hot Tub - A hot tub is disclosed having a plurality of walls defining an upper perimeter and a central well for holding a measure of heated water. A recirculation system is provided comprising a pump in fluid communication with the well. The pump is configured to direct water from the well for treatment by at least one treatment device selected from the group consisting of a filter, a heater, and a chemical diffuser. A waterfall fountain extends along each of the plurality of walls along the upper perimeter. The waterfall fountain is in fluid communication with the pump downstream of the treatment device and is configured to receive at least a portion of water treated by the treatment device and to direct the treated water back into the well. | 2015-12-24 |
20150366753 | Pill Organizer - A pill organizer having a plurality of storage compartments in which pills can be stored. The device includes a housing having recessed areas in which several elongated containers can be removably positioned. The elongated containers are separated into multiple compartments each having a hinged lid. The compartments are arranged in a grid so as to represent the days of the month. The compartments further include numbered indicia on the lid thereof. The housing further includes a digital display thereon for showing the day of the month, and optionally the full date and time. A notepad is provided on the housing for allowing the user to write notes and reminders regarding his or her medication. Thus, the present invention provides a device that allows a user to more easily store and organize his or her medications. | 2015-12-24 |
20150366754 | MEDICAL CONTAINER - The present invention provides a medical container: that is configured of an upper member and a lower member; that can be molded by injection molding; that has an excellent dimensional accuracy; and in addition to these, that is capable of effectively preventing the trouble that a molten resin for joining the upper member and the lower member enters the container. The present invention is a bottomed tubular medical container | 2015-12-24 |
20150366755 | HUMIDITY-PROOF AND CHILD-RESISTANT VIAL WITH IMPROVED IDENTIFICATION MEANS - The possibility that a child inadvertently unlocks a child-resistant vial by triggering the latch with his teeth is avoided by preventing access to the latch from under the cap. This is achieved by covering all sides of the latch with the exception of the front face thereof intended to be used to trigger the latch while the cap is lifted. Improvement of the humidity barrier in such a vial is achieved by closing the vial container with a cap including a recess that defines inner and outer peripheral walls in the cap. The inner and outer walls together define an annular gap that is configured to complementary receive the peripheral flange of the container. Both the edge of the inner wall of the cap and the inner peripheral wall of the container are provided with sealing rings that are axially distanced when the cap closes the vial container. | 2015-12-24 |
20150366756 | DELAMINATION RESISTANT PHARMACEUTICAL GLASS CONTAINERS CONTAINING ACTIVE PHARMACEUTICAL INGREDIENTS - The present invention is based, at least in part, on the identification of a pharmaceutical container formed, at least in part, of a glass composition which exhibits a reduced propensity to delaminate, i.e., a reduced propensity to shed glass particulates. As a result, the presently claimed containers are particularly suited for storage of pharmaceutical compositions and, specifically, a pharmaceutical solution comprising a pharmaceutically active ingredient. | 2015-12-24 |
20150366757 | APPARATUS FOR WEIGHT BASED SINGLE DOSES OF MEDICATION - An apparatus comprises a container comprising a volume. The volume is configured to retain a single dose of a medication appropriate for a specific classification of a weight of a patient. A first indicia is disposed on an exterior surface of the container. The first indicia indicates a type of the medication. A second indicia is disposed on the exterior surface. The second indicia indicates the specific classification, wherein the container, pre-packaged with the single dose, is appropriate for a single use dosing of the patient having the specific classification. | 2015-12-24 |
20150366758 | VIAL SHIELD - A vial shield ( | 2015-12-24 |
20150366759 | Illuminating Baby Bottle with Removable Container - An illuminating baby bottle with a removable container includes a first container, a second container, a release mechanism, a connecting member, a liquid-flowing system, a bottle cap, and a lighting device. The first container and the second container are axially attached to each other through the connecting member while the release mechanism is concentrically positioned in between the first container and the connecting member. The release mechanism selectively rotates in between a locked position and an unlocked position in such a way that the locked position separately stores baby formula and water while the unlocked position allows the mixing of baby formula and water. The liquid-flowing system releases baby formula mixture from the first container so that infants or young children can be fed with the baby formula mixture. The lighting device is positioned on the bottle cap and can selectively operate in between an on-position and an off-position. | 2015-12-24 |
20150366760 | Nasogastric tube anti aspiration device - An anti-aspiration device for a medical tube may comprise of at least one expandable/extendable membrane that once inserted within the cavity of an organ, will abut against interior walls of the cavity of the organ thereby creating a seal to reduce aspiration. One alternate embodiment may comprise of at least two membranes. Another alternate embodiment may comprise of a membrane configured to conform to the boundaries of the interior walls of the cavity of the organ. The device may include sensors and alert system to further enhance the attention towards needed adjustment or removal of the medical tube. | 2015-12-24 |
20150366761 | Kink-Resistant Tubing - Tubing for use in gastrointestinal applications includes a hollow tube and a spring positioned inside the tube. The spring is corrosion resistant and helps to prevent kinking of the tubing when the tubing is bent. An encapsulant may be positioned over the spring. The spring may be co-extruded with the tubing. | 2015-12-24 |
20150366762 | Slurry Powder Cosmetic Compositions And Methods - Slurry powder cosmetic composition comprising particulates coated with a binder composition and the evaporation residue of an aqueous based composition comprising at least one water soluble or water dispersible polymer, and a method for making the composition. | 2015-12-24 |
20150366763 | Eyeliner Decal Composition and Method of Use - The present invention relates to compositions including humectant, colorant, matting agent, pH modifier, film forming agent, rheology modifier, and adhesive, as well as methods of producing such compositions and using such compositions for cosmetics especially adapted for use as eyeliners. | 2015-12-24 |
20150366764 | EFFERVESCENT TABLET FOR ELIMINATION OF RED WINE DISCOLORATION, OFFENSIVE ODOUR OF MOUTH AND CLEANING THE PALATE - The embodiments herein discloses a composition and method for the synthesis of an effervescence producing tablet for reducing and eliminating a mouth odour and oral staining caused by ingested beverages and food. The method comprises mixing excipients, disintegrating agents, flavour and sweetener in a V-blender. The lubricant is added V-blender to obtain a mixture. The mixture is compressed on tablet press equipment with a round tooling. The tablets are packaged in a foil pouch. The “excipients” in the effervescent tablet composition are malic acid, sorbitol, potassium bi-carbonate, microcrystalline cellulose, sodium chloride, sodium carbonate and magnesium oxide. The malic acid react with potassium bicarbonate or sodium bicarbonate or sodium carbonate to form an effervescence reaction to induce tablet disintegration, provide a pleasant sensation in the mouth, and to clean a wine stain in the mouth. | 2015-12-24 |
20150366765 | Method For Making An Emulsified Antiperspirant Product - Methods for making antiperspirant products that are in the form of emulsions comprising a continuous water-immiscible phase and a disperse aqueous phase. | 2015-12-24 |
20150366766 | PEROXIDE-STABLE ORAL CARE COMPOSITIONS - Described herein are oral care compositions comprising (i) a peroxide whitening agent comprising a whitening complex of crosslinked polyvinylpyrrolidone complexed with hydrogen peroxide, (ii) sodium acid pyrophosphate (Na | 2015-12-24 |
20150366767 | NON-STAINING TOOTHPASTE - The present invention relates to a dentifrice which does not excessively stain toothbrush bristles, for example, a pigmented toothpaste formulations having a pigment system which comprises (i) a dissolvable or disintegratable film comprising one or more releasable pigments which are released during brushing, and (ii) titanium dioxide, wherein the level of titanium dioxide is 0.01-0.375% by weight of the toothpaste; together with methods of making and using the same. | 2015-12-24 |
20150366768 | Oral Care Composition - An oral care composition is provided. The composition comprises (a) a first component comprising an amine fluoride; and (b) a second component comprising an acidic polymer; wherein the amine fluoride and acidic polymer have respective first and second reactive groups which are arranged to react together to form a cross-linked copolymer of the amine fluoride and acidic polymer when the composition is applied to an oral cavity. | 2015-12-24 |
20150366769 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE, AN ORGANIC UVB-SCREENING AGENT AND AN ADDITIONAL ORGANIC UVA-SCREENING AGENT - The present invention relates to a cosmetic or dermatological composition comprising, in a physiologically acceptable support: a) at least one oily phase and b) at least one merocyanine compound of formula (1) defined hereinbelow and c) at least one organic UVB-screening agent chosen from: v) a liquid lipophilic organic UVB-screening agent vi) a hydrophilic organic UVB-screening agent vii) a triazine UVB-screening agent and viii) mixtures thereof; and d) at least one organic UVA-screening agent other than the said merocyanine compound; when the said UVB-screening agent is liquid and lipophilic, the said composition contains less than 2% by weight of cyclohexasiloxane relative to the total weight of the composition. Another subject of the present invention consists of a non-therapeutic cosmetic process for caring for and/or making up a keratin material, comprising the application, to the surface of the said keratin material, of at least one composition according to the invention as defined above. The invention also relates to a non-therapeutic cosmetic process for limiting the darkening of the skin and/or improving the colour and/or uniformity of the complexion, comprising the application, to the surface of the keratin material, of at least one composition as defined previously. The invention also relates to a non-therapeutic cosmetic process for preventing and/or treating the signs of ageing of a keratin material, comprising the application, to the surface of the keratin material, of at least one composition as defined previously. | 2015-12-24 |
20150366770 | COMPOSITION FOR COSMETIC USE SUITABLE TO PRODUCE A PIGMENTATION EFFECT ON HAIR - The invention concerns the use of compounds with formula (I) R—N1-spermidine, or 1,4-butandiamin,N-(3-amino propyl)-N1-R, (I) H | 2015-12-24 |
20150366771 | DYE COMPOSITION USING AT LEAST ONE COUPLER OF META-PHENYLENEDIAMINE TYPE SUBSTITUTED IN POSITION 4 IN A MEDIUM COMPRISING A FATTY SUBSTANCE, PROCESSES AND DEVICE - The present invention relates to a composition for dyeing keratin fibres, in particular human keratin fibres such as the hair, comprising one or more fatty substances, one or more surfactants, one or more oxidation bases chosen from para-phenylenediamines, bis(phenyl)alkylenediamines, para-aminophenols, ortho-aminophenols and the addition salts thereof and/or solvates thereof one or more particular couplers of meta-phenylenediamine type substituted in position 4, and one or more basifying agents, the fatty substance content in the dye composition representing in total at least 10% by weight relative to the total weight of the said composition. The invention also relates to a dyeing process using such a composition, and also to multi-compartment devices suitable for performing the said process. | 2015-12-24 |
20150366772 | MULTI-TONAL ONE-STEP DYES - A cosmetic agent (A) is applied to the fibers and allowed to act for a time period from 30 seconds to 30 minutes. Then a cosmetic agent (B) is applied to the keratinic fibers still being acted upon by agent (A), and both agents (A) and (B) are allowed to act for a time period from 5 to 45 minutes, whereupon agents (A) and (B) are rinsed out. Agent (A) (a1) contains one or more oxidation dye precursors of the developer type, (a2) does not contain an oxidation dye precursor of the coupler type, (a3) has a pH from 8.0 to 12.0, and agent (B) (b1) contains one or more oxidation dye precursors, (b2) contains one or more oxidizing agents, and (b3) has a pH from 8.0 to 12.0. | 2015-12-24 |
20150366773 | MULTI-TONAL ONE STEP DYEING - A cosmetic agent (A) is applied to the fibers and allowed to act for a time period from 30 seconds to 30 minutes. Then a cosmetic agent (B) is applied to the keratinic fibers still being acted upon by agent (A), and both agents (A) and (B) are allowed to act for a time period from 5 to 45 minutes, whereupon agents (A) and (B) are rinsed out. Agent (A) (a1) contains one or more oxidation dye precursors of the developer type, (a2) contains one or more oxidation dye precursors of the coupler type, (a3) has a pH from 8.0 to 12.0, and agent (B) (b1) contains one or more oxidation dye precursors, (b2) contains one or more oxidizing agents, and (b3) has a pH from 8.0 to 12.0. | 2015-12-24 |
20150366774 | INTERNAL OLEFIN SULFONATE COMPOSITION - Provided are an internal olefin sulfonate composition which is capable of sufficiently enhancing foamability, foam lubricity and volume of foam, and a cleansing composition containing the same. | 2015-12-24 |
20150366775 | INTERNAL OLEFIN SULFONATE COMPOSITION - Provided are an internal olefin sulfonate composition which is capable of sufficiently enhancing foamability, light foam quality, and instantaneous foam dissipation property, and a cleansing composition containing the internal olefin sulfonate composition. The internal olefin sulfonate composition comprises (A) an internal olefin sulfonate having 12 carbon atoms and (B) an internal olefin sulfonate having 14 carbon atoms, wherein a content mass ratio of the component (A) to the component (B), (A/B), is from 10/90 to 90/10, and a total content of the component (A) and the component (B) in the internal olefin sulfonate is from 60 to 100% by mass. | 2015-12-24 |
20150366776 | NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREOF - Provided are a novel compound having skin-whitening, anti-oxidizing and PPAR activities and a medical use thereof, and the compound has skin-whitening activities for the suppression of tyrosinase, and accordingly, is useful for use in skin-whitening pharmaceutical composition or cosmetic products; has anti-oxidant activities, and accordingly, is useful for the prevention and treatment of skin-aging; and has PPAR activities, and in particular, PPARα and PPARγ activities, and accordingly, is useful for use in pharmaceutical compositions or health foods which are effective for the prevention and treatment of obesity, metabolic disease, or cardiovascular disease. | 2015-12-24 |
20150366777 | COMBINATION OF SKIN PROTECTION AGAINST DAMAGES CAUSED BY INFRARED RADIATION - A combination of at least one SIRT1 peptide activator and at least one guanosine derivative alarmone, in a dermatological cosmetic for providing protection against damages caused by infrared radiation. | 2015-12-24 |
20150366778 | ORAL CARE WHITENING COMPOSITIONS - Described herein are whitening compositions comprising a peroxide source, and an adhesion system comprising a hydrophobic component comprising a silicone adhesive; and a dental surface adhesion enhancing agent, which are physically stable and effectively provide whitening. Methods of making and using these compositions are also described herein. | 2015-12-24 |
20150366779 | SOLID LIPSTICK COMPOSITION HAVING IMPROVED HARDNESS - Disclosed is a solid lipstick composition comprising at least one polypropyl silsesquioxane film forming resin, at least one silicone acrylate copolymer, at least one volatile hydrocarbon solvent, and at least one wax, wherein the ratio of the silicone acrylate copolymer to the polypropyl silsesquioxane resin is from about 1:1 to about 1:4, said composition preferably having a hardness of at least 40 gf for an 8.1 mm diameter stick. | 2015-12-24 |
20150366780 | LIPSTICK COMPOSITION HAVING IMPROVED COMFORT - Provided are cosmetic compositions comprising a silicone acrylate copolymer, a polypropylsilsesquioxane film forming resin, a hydrocarbon-based resin, a non-volatile oil, a volatile hydrocarbon solvent, and optionally a wax, wherein the ratio of the silicone acrylate copolymer to the polypropylsilsesquioxane resin is from about 1:1 to about 4:1, the weight percent ratio of silicone acrylate copolymer plus the polypropylsilsesquioxane film forming resin to the at least one hydrocarbon-based resin is from about 1.5:1 to about 30:1 on a dry weight basis, and the total amount of the polypropyl silsesquioxane film forming resin and the silicone acrylate copolymer is greater than about 10% on a dry weight basis relative to the weight of the composition. | 2015-12-24 |
20150366781 | COSMETIC PREPARATION CONTAINING CROSSLINKABLE SILICONE RUBBER EMULSION AND ITS PRODUCTION METHOD - A cosmetic preparation containing a crosslinkable silicone rubber emulsion comprising (A) 100 parts by weight of a straight chain or branched organopolysiloxane containing at least two hydroxyl groups bonded to the silicon atom per molecule prepared by ring-opening polymerization of a cyclic organosiloxane in the presence of an alkoxysilane or its partial hydrolytic condensate or an α,ω-dihydroxy or dialkoxy siloxane oligomer by using a catalyst selected from citric, lactic, and ascorbic acids and an anionic surfactant emulsifier; and (B) 0.5 to 20 parts by weight of a reaction product of an amino group-containing organoxysilane and an acid anhydride. | 2015-12-24 |
20150366782 | LIPSTICK COMPOSITION HAVING IMPROVED GLOSS AND WEAR - Disclosed is a lipstick composition comprising at least one silicone acrylate copolymer, at least one polypropylsilsesquioxane film forming resin, at least one polypropylsilsesquioxane wax substituted with alkyl units having at least 30 carbons, and at least one volatile hydrocarbon solvent, wherein ratio of the silicone acrylate copolymer to the polypropylsilsesquioxane resin is from about 1:1 to about 4:1. | 2015-12-24 |
20150366783 | COSMETIC COMPOSITION COMPRISING HYDROPHOBIC SILICA AEROGEL PARTICLES, A WAX, A HYDROCARBON OIL AND A FATTY ALCOHOL AND/OR A FATTY ACID - The present invention relates to a cosmetic composition comprising: —hydrophobic silica aerogel particles, —at least one wax, —at least one hydrocarbon oil and —at least one fatty alcohol and/or at least one fatty acid, the composition comprising at least 10% by weight of wax(es), with respect to the total weight of the composition. | 2015-12-24 |
20150366784 | COSMETIC COMPOSITIONS AND USES THEREOF - Disclosed are cosmetic composition useful for the cleansing, moisturizing, and/or treating or soothing of skin or hair. Also disclosed are methods of using the cosmetic compositions and kits and containers comprising the cosmetic composition. The cosmetic compositions described herein are a combination of conditioning agents, thickening agents, fragrances, UV absorption agents, pH adjusters, moisturizing agents, preservatives, and salts. | 2015-12-24 |
20150366785 | EXTERNAL SKIN PREPARATION - An external skin preparation containing an edelweiss extract, and one or more extracts selected from the group consisting of extracts of plants belonging to the genus | 2015-12-24 |
20150366786 | DENTAL VARNISH COMPOSITIONS - A one-part dental varnish includes a solution of a rosin and a resin in a common solvent and further includes a fluoridizing agent. The dental varnish is transparent and contains about 18 to about 60 percent by weight rosin and about 25 to about 60 percent by weight resin. | 2015-12-24 |
20150366787 | SESBANIA ACULEATA EXTRACTS AND METHODS OF USE - Methods of using extracts of | 2015-12-24 |
20150366788 | CALOTROPIS GIGANTEA EXTRACTS AND METHODS OF USE - Methods of using extracts of | 2015-12-24 |
20150366789 | GLOCHIDIUM WALLICHIANUM EXTRACTS AND METHODS OF USE - Methods of using extracts of | 2015-12-24 |
20150366790 | PLUMERIA ACUMINATA EXTRACTS AND METHODS OF USE - Methods of using extracts of | 2015-12-24 |
20150366791 | Compositions for Improving the Health and Appearance of Skin - Provided herein are microalgal skin care compositions and methods of improving the health and appearance of skin. Also provided are methods of using polysaccharides for applications such as topical personal care products, cosmetics, and wrinkle reduction compositions. The invention also provides novel decolorized microalgal compositions useful for improving the health and appearance of skin. The invention also includes insoluble polysaccharide particles for application to human skin. | 2015-12-24 |
20150366792 | PROBIOTIC ARGINOLYTIC ORAL COMPOSITIONS AND METHODS OF MAKING AND USING PROBIOTIC ARGINOLYTIC ORAL COMPOSITIONS - The present disclosure provides probiotic arginolytic oral compositions, methods of making probiotic arginolytic oral compositions, and methods of using probiotic arginolytic oral compositions to increase arginolytic activity in the oral cavity and/or to treat and/or prevent caries. | 2015-12-24 |
20150366793 | TRANSMUCOSAL DELIVERY DEVICES WITH ENHANCED UPTAKE - The present invention provides methods for enhancing transmucosal uptake of a medicament, e.g., fentanyl or buprenorphine, to a subject and related devices. The method includes administering to a subject a transmucosal drug delivery device comprising the medicament. Also provided are devices suitable for transmucosal administration of a medicament to a subject and methods of their administration and use. The devices include a medicament disposed in a mucoadhesive polymeric diffusion environment and a barrier environment. | 2015-12-24 |
20150366794 | USE OF BETHANECHOL FOR TREATMENT OF XEROSTOMIA - Bethanecol is administered topically, for the treatment of xerostomia. | 2015-12-24 |
20150366795 | TOPICAL ANTIVIRAL FORMULATIONS - The present invention relates to formulations of nucleotide reverse transcriptase inhibitors (NRTIs), preferably [2-(6-Amino-purin-9-yl)-1-methyl-ethoxymethyl]-phosphonic acid (tenofovir, PMPA), or a physiologically functional derivative thereof, suitable for topical application and their use in the prevention of HIV infections. | 2015-12-24 |
20150366796 | INTRADERMAL DELIVERY OF IMMUNOLOGICAL COMPOSITIONS COMPRISING TOLL-LIKE RECEPTOR AGONISTS - An intradermal delivery system comprises an immunogenic composition comprising a TLR agonist and immunogen and a microneedle. The immunogenic composition may comprise a solid biodegradable microneedle or a solid coated microneedle. The intradermal delivery system may be formulated into a skin patch. | 2015-12-24 |
20150366797 | METHODS OF TREATING MICROBIAL INFECTIONS, INCLUDING MASTITIS - The invention includes methods and compositions for treating mastitis in a subject. The method includes the step of administering, by intramammary delivery, a therapeutically effective amount of a polyether ionophore, or a therapeutically acceptable salt thereof, to the mammary gland of the subject. | 2015-12-24 |
20150366798 | PHARMACEUTICAL ADHESIVE COMPOSITIONS FOR TREATMENT OF EPISTAXIS AND METHODS OF USE THEREOF - The present invention provides liquid adhesive compositions including at least one silicone resin film forming agent, at least one surfactant, at least one volatile solvent, water and at least one vasoconstrictor, where the compositions are in the form of an emulsion. The invention further provides methods for treating any type of nose bleeding, including Epistaxis, including administering the liquid adhesive compositions to the nose, in the affected nostril. Further provided is a kit, including the liquid adhesive composition and a container-applicator device. | 2015-12-24 |
20150366799 | METHOD OF TREATING ALLERGIC CONJUNCTIVITIS WITH CYCLOSPORIN COMPOSITIONS - Disclosed herein is a method of treating allergic conjunctivitis, the method comprising the step of topically administering to an eye affected with such a condition a composition comprising cyclosporin, at a concentration between about 0.001% (w/v) to about 0.01% (w/v). | 2015-12-24 |
20150366800 | ANDROGEN COMPOSITION FOR TREATING AN OPTHALMIC CONDITION - The disclosure provides compositions for treating an ocular condition. The composition comprises a physiologically effective amount of an androgen, wherein the composition is suitable for topical administration to an eye. The disclosure further provides methods for treating an ocular condition with the disclosed compositions. | 2015-12-24 |
20150366801 | Rapidly Dispersible Dosage Form of Topiramate - A taste-masked rapidly dispersible dosage form of topiramate is provided. Wax coated particles of topiramate are included within a porous bound matrix. The topiramate retains its taste-masked form after dispersion in the mouth of a subject even though the particles are not coated with a polymeric material. The dosage form disperses in saliva or water in less than 2 min even though it has a high content of wax. It can be used to treat diseases or disorders that are therapeutically responsive to topiramate or a derivative thereof. | 2015-12-24 |
20150366802 | Rapidly Dispersible Dosage Form of Oxcarbazepine - A high dose orodispersible dosage form of oxcarbazepine is provided. Drug-containing particles of oxcarbazepine are included within a porous bound matrix. The dosage form disperses in saliva or water in less than 15 sec and it has sufficient hardness to withstand handling and storage. It can be used to treat diseases or disorders that are therapeutically responsive to oxcarbazepine or a derivative thereof. | 2015-12-24 |
20150366803 | NRF2 Screening Assays and Related Methods and Compositions - Provided are certain methods of screening, identifying, and evaluating neuroprotective compounds useful for treatment of neurological diseases, such as, e.g., multiple sclerosis (MS). The compounds described upregulate the cellular cytoprotective pathway regulated by Nrf2. Also provided are certain methods of utilizing such compounds in therapy for neurological disease, particularly, for slowing or reducing demyelination, axonal loss, or neuronal and oligodendrocyte death. | 2015-12-24 |
20150366804 | Pharmaceutical Compositions Comprising Multi-Component Crystalline Particles Suitable for Use in Inhalation Therapy - Pharmaceutical compositions comprising multi-component crystalline particles suitable for use in inhalation therapy and for delivery by oral or nasal inhalation are provided, wherein said compositions additionally comprise particles of at least one additional active agent. Also provided are methods of preparation of the compositions and their use in medicine. | 2015-12-24 |
20150366805 | POROUS SILICA GEL AS A CARRIER FOR LIQUID TECHNOLOGIES - Compositions containing a biologically active ingredient and an inorganic oxide material are disclosed. Methods of making and using compositions containing a biologically active ingredient and an inorganic oxide material are also disclosed. The present invention relates to compositions comprising inorganic oxide porous material containing a biologically active ingredient in liquid form, methods of making such compositions, and methods of using them. | 2015-12-24 |
20150366806 | Method of Engineering Nanoparticle - The present invention relates to methods to guide the engineering of nanoparticle drugs for intravenous administration based on various pharmacokinetic parameters and other tests. The methods of the present invention have particular use in formulating nanoparticles containing cytotoxic drugs for the treatment of cancer. The guiding principles are properties which facilitate the release of drugs into the patient including unstable in plasma/blood, low AUC, low C | 2015-12-24 |
20150366807 | ORAL PHARMACEUTICAL COMPOSITION COMPRISING DABIGATRAN ETEXILATE - The present invention relates to an oral pharmaceutical composition comprising dabigatran etexilate or a pharmaceutically acceptable salt thereof, methods for preparing it and dosage forms for oral administration comprising said composition. The pharmaceutical composition is particularly useful as a medicament, especially as anticoagulant. | 2015-12-24 |
20150366808 | Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof - A dual release oral dosage system/dosage form comprising an immediate release component/composition and a delayed release component/composition is described. Each of the immediate release component/composition and delayed release component/composition comprises one or more of doxylamine, an analog thereof, a derivative thereof, a prodrug thereof, a metabolite thereof and/or a salt thereof, and one or more of pyridoxine, a salt thereof, a metabolite thereof and/or a salt of the metabolite. The dual release oral dosage system/dosage form exhibits an improved pharmacokinetic profile relative to the current Diclectin® formulation and is useful for example for the alleviation of the symptoms of nausea and vomiting, for example in the case of nausea and vomiting in pregnancy (NVP). | 2015-12-24 |
20150366809 | OXIDATION-STABILIZED TAMPER-RESISTANT DOSAGE FORM - A thermoformed pharmaceutical dosage form having a breaking strength of at least 300 N, said dosage form comprising
| 2015-12-24 |
20150366810 | SUSTAINED-RELEASE SOLID PREPARATION FOR ORAL USE - It is intended to avoid dose dumping of a drug and improve the dissolution properties of the drug in the lower gastrointestinal tract, and thereby provide a sustained-release matrix preparation for oral administration that reliably exhibits its main pharmacological effect when orally administered once or twice a day. The present invention provides a sustained-release matrix preparation comprising (A) a pharmacologically active drug, (B) a combination of cellulose derivatives, and (C) mannitol. | 2015-12-24 |
20150366811 | PHARMACEUTICAL PRODUCTS - Disclosed in certain embodiments is a dosage form comprising a plurality of extruded particles comprising an adverse agent or antagonist and a layer disposed about the particles. | 2015-12-24 |
20150366812 | DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION - The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases. | 2015-12-24 |
20150366813 | LIQUID-FILLED IMMEDIATE RELEASE SOFT GELATIN CAPSULES - Described herein are oral pharmaceutical compositions comprising labile, air-, moisture-, or heat-sensitive active pharmaceutical ingredients and methods for making the same. In particular, immediate release capsules comprising non-aqueous fills comprising moisture-sensitive active pharmaceutical ingredients are described. | 2015-12-24 |
20150366814 | ALL-NATURAL ENTERIC SOFT CAPSULES COMPRISING ACTIVE INGREDIENTS - Described herein are soft capsules and enteric soft capsules comprising cationic Type A gelatin and acid insoluble enteric polymers. In particular, the compositions and methods for manufacturing all-natural enteric soft capsules comprising Type A gelatin and matrix fills are described. In one embodiment, the enteric soft capsules comprise active ingredients such as non-steroidal anti-inflammatory drugs (NSAIDs). In another embodiment, the enteric soft capsule comprises matrix fills of omega-3 fatty acids. | 2015-12-24 |
20150366815 | ENTERIC SOFT CAPSULE COMPOSITIONS - Described herein are enteric soft capsules comprising gastric resistant polymers and gelatin and methods for manufacturing the same. The enteric soft capsules described herein have enhanced enteric and elastic properties and are simpler to manufacture and produce. | 2015-12-24 |
20150366816 | Compositions for Treatment of Attention Deficit Hyperactivity Disorder - Therapeutic compositions and methods for treatment of attention deficit disorder (ADD) or attention deficit hyperactivity disorder (ADHD) include dosage forms that deliver a therapeutic amount of active drug in a delayed and controlled release formulation. The dosage form can be administered at night and drug release is delayed for from 5 to 8 hours or longer, followed by a prolonged release. | 2015-12-24 |
20150366817 | DELAYED-RELEASE FORMULATIONS, METHODS OF MAKING AND USE THEREOF - Compositions for reducing the frequency of urination and methods of manufacture of the compositions are disclosed. One method of manufacture include the steps of forming a first mixture comprising a first active ingredient comprising one or more analgesic, coating the first mixture with a first delayed-release coating to form a first component, forming a second mixture comprising a second active ingredient comprising one or more analgesic agents, coating the second mixture with a second delayed-release coating to form a second component, and combining the first component with the second component to form a third mixture. | 2015-12-24 |
20150366818 | Nanoparticles containing a Taxane and their Use - Symmetrically and asymmetrically branched homopolymers are modified at the surface level with functional groups that enable forming aggregates with a taxane, such as, paclilaxei and its derivatives, which are water insoluble or poorly water soluble. The aggregates are formed by interaction of a taxane and a homopolymer. Such aggregates improve drug solubility, stability, delivery and efficacy. | 2015-12-24 |
20150366819 | COMPOSITIONS AND METHODS FOR TREATING HOOF DISEASES - The present invention is generally directed to compositions and methods for the treatment of an infectious disease of the foot of an animal. One aspect of the invention is directed to a method for preventing and/or treating one or more infectious diseases of the hoof in animals, comprising: preparing a copper-free and zinc-free composition comprising at least one cross-linking agent, wherein the cross-linking agent is not formaldehyde; and administering the composition to a lower leg and hoof area of said animal to prevent and/or treat said one or more infectious diseases. Another aspect of the invention is directed to a copper-free and zinc-free composition for the treatment and/or prevention of one or more infectious diseases of the hoof in animals, comprising at least one cross-linking agent, wherein said cross-linking agent is not formaldehyde. The present invention is also directed to a method for treating and/or preventing papillomatous digital dermatitis in an ungulate, comprising: preparing a copper-free and zinc-free composition comprising at least one cross-linking agent and at least one quaternary ammonium compound; and spraying or applying in a foam a therapeutically effective amount of said composition to a lower leg and hoof area of said ungulate in order to treat and/or prevent said papillomatous digitial dermatitis. | 2015-12-24 |
20150366820 | METHOD FOR PREVENTING AND/OR TREATING THE FORMATION OF INJURY OF LIVER AND ORAL COMPOSITION FOR USE IN SUCH METHOD - A method for preventing and/or treating the formation of liver injury resulting from lipid accumulation in hepatocytes and/or inflammation of liver tissue and/or fibrosis in liver tissue and/or Non-Alcoholic Steatohepatitis (NASH) and/or alcoholic consumption and/or other toxic causes of liver injury by is performed by administering of iso-alpha-acid. An oral composition may be used. | 2015-12-24 |
20150366821 | ADRENERGIC AGONISTS FOR USE IN TREATING LIVER DAMAGE - The invention relates to liver damage, and to pharmaceutical compositions for use in treating, preventing or ameliorating liver damage or disease, especially acute liver damage. The invention is particularly, although not exclusively, concerned with treating or preventing liver damage caused by paracetamol poisoning. The invention also extends to methods of treating such conditions. | 2015-12-24 |
20150366822 | TOPICAL ANTIFUNGAL COMPOSITION FOR TREATING ONYCHOMYCOSIS - The present invention is directed to a nail lacquer consisting essentially of terbinafine as an antimycotic agent, hydroxypropyl chitosan as film forming agent, water and a lower alkanol as solvents. The invention is also directed to a method for treating onychomycosis by topically administering such a nail lacquer to a patient in need of such a treatment. | 2015-12-24 |
20150366823 | PHARMACEUTICAL COMPOSITIONS INCORPORATING LOW-DOSE DRUGS - The present invention relates to novel pharmaceutical compositions in powder or granule form which comprise a low-dose drug attached to a water-soluble carrier, such as by adhesion or adsorption. The compositions further comprise an oily liquid which facilitates the attachment of the active ingredient to the carrier particles. Moreover, the invention provides methods for preparing such powders or granules, and compressed tablets incorporating them. | 2015-12-24 |
20150366824 | INDUCTION OF ESTROGEN RECEPTOR BETA BY CHOLESTEROL BIOSYNTHESIS INHIBITORS AND METHODS OF TREATMENT OF CANCER - Disclosed herein are methods and compositions related to the discovery that cholesterol inhibitors induce the anti-proliferative protein, estrogen receptor beta (ERβ), in both ERα-positive and ERα-negative breast cancer cell lines, including triple negative cells. | 2015-12-24 |
20150366825 | MULTIPARTICULATE PHARMACEUTICAL COMPOSITION COMPRISING A MULTITUDE OF TWO KINDS OF PELLETS - Multiparticulate pharmaceutical composition comprising a multitude of two kinds of pellets, A and B, each comprising metoprolol or a pharmaceutically acceptable salt thereof as an active pharmaceutical ingredient, wherein the pellets A are coated with a coating layer comprising at least 30% by weight of a polymeric compound consisting of one or more (meth)acrylate copolymers polymerized from 20 to 40% by weight of ethyl acrylate, 60 to 80% by weight of methyl methacrylate and 0 or less than 5% by weight of methacrylic acid or acrylic acid, in an amount sufficient to result in an active pharmaceutical ingredient release profile according to USP in pH 6.8 test medium with a release rate of less than 20% after 4 hours, wherein the pellets B are not coated or coated with a coating layer and show an active pharmaceutical ingredient release profile according to USP in pH 6.8 test medium with an active pharmaceutical ingredient release rate of more than 40% after 4 hours, wherein the metoprolol release rate of the pellets A in pH 1.2 test medium according to USP with the addition of 40% (v/v) ethanol is •not more than 15% after 15 minutes •more than 15 up to 40% after 30 minutes, wherein the metoprolol release rate of the pellets B in pH 1.2 test medium according to USP with the addition of 40% (v/v) ethanol is •more than 15% after 15 minutes •more than 40% after 30 minutes and wherein the pellets A and B are present in the multiparticulate pharmaceutical composition in a relation resulting in a combined active pharmaceutical ingredient release profile of the multiparticulate pharmaceutical composition according to USP in pH 6.8 test medium with releases rates of •not more than 25% after 1 hour •20 to 40% after 4 hours •40 to 60% after 8 hours •not less than 80% after 20 hours. | 2015-12-24 |
20150366826 | PHARMACEUTICAL FORMULATION FOR REDUCING BLADDER SPASMS AND METHOD OF USE THEREOF - Methods and compositions for reducing bladder spasms are disclosed. The methods comprise administering to a subject in need thereof a pharmaceutical composition comprising an effective amount of acetaminophen and an effective amount of at least one non-steroidal anti-inflammatory agent (NSAID). In another embodiment, a method for reducing bladder spasms comprising administering to a subject in need thereof a pharmaceutical composition comprising an effective amount of at least one prostaglandin (PG) pathway inhibitor, wherein the at least one PG pathway inhibitor is not acetaminophen or an NSAID. | 2015-12-24 |